drugset / Trial / NCT02966080

Fixed Low-dose Heparin Versus Standard Adjusted-dose Heparin Infusion in Adults Receiving Venovenous ECMO With a Heparin Bonded Circuit.

NCT02966080

RandomizedParallel-groupOpen-labelSupportive care

Summary

Heparin is a blood thinner used to prevent blood clots in patients on a form of life-support called ECMO. Heparin can cause bleeding - the most common complication of ECMO. New materials used in ECMO machines may help prevent clots - this could allow the use of lower doses of heparin which might reduce the risk of bleeding. Our study will compare low dose to high dose heparin in patients on ECMO. We think low dose heparin may be adequate to prevent clotting, but may cause less bleeding and be safer for patients.

Timeline

Start
2016-12
Primary completion
2020-12
Completion
2021-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Heparin Other / unclassified 500 iu Intravenous